Kyung Dong Pharmaceutical Co. Ltd (011040) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.025x

Based on the latest financial reports, Kyung Dong Pharmaceutical Co. Ltd (011040) has a cash flow conversion efficiency ratio of 0.025x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.70 Billion ≈ $3.86 Million USD) by net assets (₩229.60 Billion ≈ $155.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Kyung Dong Pharmaceutical Co. Ltd to measure how much of total assets are equity-financed.

Kyung Dong Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Kyung Dong Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 011040 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Kyung Dong Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kyung Dong Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cheryong Industrial Co.Ltd KQ:147830	0.138x
Solitario Exploration & Royalty Corp NYSE MKT:XPL	-0.019x
Ba Ria Vung Tau House Development JSC VN:HDC	-0.001x
Calitech Co Ltd TWO:6532	0.019x
Lavras Gold Corp V:LGC	-0.018x
Starry Sea Acquisition Corp Ordinary Shares NASDAQ:SSEA	-0.010x
EcoGraf Ltd F:FMK	-0.018x
DeFi Development Corp. NASDAQ:DFDV	-0.963x

Annual Cash Flow Conversion Efficiency for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Kyung Dong Pharmaceutical Co. Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩228.87 Billion ≈ $155.10 Million	₩16.93 Billion ≈ $11.48 Million	0.074x	+301.66%
2024-12-31	₩220.06 Billion ≈ $149.13 Million	₩-8.07 Billion ≈ $-5.47 Million	-0.037x	-26148.62%
2023-12-31	₩228.48 Billion ≈ $154.84 Million	₩-31.94 Million ≈ $-21.64K	0.000x	+96.66%
2022-12-31	₩257.20 Billion ≈ $174.30 Million	₩-1.07 Billion ≈ $-728.49K	-0.004x	-108.74%
2021-12-31	₩259.82 Billion ≈ $176.08 Million	₩12.42 Billion ≈ $8.42 Million	0.048x	-26.76%
2020-12-31	₩262.19 Billion ≈ $177.68 Million	₩17.12 Billion ≈ $11.60 Million	0.065x	+632.25%
2019-12-31	₩226.71 Billion ≈ $153.64 Million	₩-2.78 Billion ≈ $-1.88 Million	-0.012x	-107.81%
2018-12-31	₩211.72 Billion ≈ $143.48 Million	₩33.27 Billion ≈ $22.55 Million	0.157x	+134.79%
2017-12-31	₩220.95 Billion ≈ $149.74 Million	₩14.79 Billion ≈ $10.02 Million	0.067x	-45.18%
2016-12-31	₩209.93 Billion ≈ $142.26 Million	₩25.63 Billion ≈ $17.37 Million	0.122x	+37.17%
2015-12-31	₩205.14 Billion ≈ $139.02 Million	₩18.26 Billion ≈ $12.37 Million	0.089x	-25.43%
2014-12-31	₩190.43 Billion ≈ $129.05 Million	₩22.73 Billion ≈ $15.40 Million	0.119x	+22.85%
2013-12-31	₩169.03 Billion ≈ $114.55 Million	₩16.42 Billion ≈ $11.13 Million	0.097x	-25.16%
2012-12-31	₩153.76 Billion ≈ $104.20 Million	₩19.96 Billion ≈ $13.53 Million	0.130x	-25.02%
2011-12-31	₩150.62 Billion ≈ $102.07 Million	₩26.08 Billion ≈ $17.67 Million	0.173x	--

About Kyung Dong Pharmaceutical Co. Ltd

KQ:011040 Korea Pharmaceuticals

Market Cap

$77.22 Million

₩113.95 Billion KRW

Market Cap Rank

#20124 Global

#1023 in Korea

Share Price

₩4845.00

Change (1 day)

+2.00%

52-Week Range

₩4720.00 - ₩6160.00

All Time High

₩14206.86